Articles By Jack Cush, MD
Ominous Outcomes for Lupus Nephritis
Hanly and coworkers have reported the results of a large lupus cohort study involving 1827 patients. SLE patients were enrolled early in their disease (0.5 years) and were followed for a mean of 4.6 years.
Read Article
ACP Backs New CDC Guideline for Opioids and Chronic Pain
Wayne J Riley, MD, MPH, MBA, MACP, president of the American College of Physicians (ACP) sent a letter to the Centers for Disease Control and Prevention (CDC) reacting to its Draft Guideline for the Use of Opioids for Chronic Pain.
Read Article
The Price of Drugs Continues to Increase
Drug prices increased an average of 10% in 2015 (after a 13.5% increase in 2014) and includes big name drugs from major pharmaceutical companies.
Read Article
What's it like to have RA - from those who do and don't
A patient recently asked me, “What do you think it’s like to have RA” and “How would you describe it to someone you just met?” Could I walk a mile in her shoes? Here's my version and theirs.
Read Article
Seropositivity Increases Risk of Rheumatoid Mortality
Three European registries analyzed their cohorts for outcomes that may be related to seropositivity for anticitrullinated protein antibodies (ACPA), rheumatoid factor (RF) and anticarbamylated protein (anti-CarP) antibodies.
Read Article
Prescribing Rules
If you are responsible for the outcome and welfare of patients – you need prescribing rules. If you are supervising others or responsible for the training of those learning rheumatology – you need prescribing rules.
Read Article
Combination or Monotherapy Tocilizumab in Rheumatoid Arthritis
Several rheumatoid arthritis studies have shown that tocilizumab (TCZ) may be as effective as monotherapy when compared to combination therapy (methotrexate plu
Read Article
Cochrane Reviews Low Back Pain and Exercise
A new Cochrane Review published today shows that targeting exercises to muscles that support and control the spine offers another strategy to reduce pain and disability caused by lower back pain.
Read Article
The Global Prevalence of Spondyloarthritis
SpA is a common disease, but with large variation in reported prevalence estimates, partly explained by differences in demographical and methodological characteristics.
Read Article
2015 Rheumatology Year in Review
Was 2015 a good year for psoriasis, IL-17, biosimilars, narcotics, the ACR and gout? Our year end review discusses the most impactful news and research from the last 12 months.
Read Article
